Evidence map›Paper›PMID 34442043›Full record

ArticleJournal of clinical medicine2021

Comparison of COVID-19 and Non-COVID-19 Pneumonia in Down Syndrome.

Diego Real de Asua, Miguel A Mayer, María Del Carmen Ortega, Jose M Borrel, Teresa de Jesús Bermejo, Domingo González-Lamuño, Coral Manso, Fernando Moldenhauer, María Carmona-Iragui, Anke Hüls and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 3 countries.

Diego Real de AsuaAdult Down Syndrome Outpatient Unit, Department of Internal Medicine, Hospital Universitario de La Princesa, 28006 Madrid, Spain.
Miguel A MayerResearch Programme on Biomedical Informatics, Hospital del Mar Medical Research Institute, 08003 Barcelona, Spain.
María Del Carmen OrtegaDepartment of Psychiatry, Research Institute i+12, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Jose M BorrelDown España Huesca, 22005 Huesca, Spain.
Teresa de Jesús BermejoUnidad de Neuropediatría, Instituto Hispalense de Pediatría, 41013 Sevilla, Spain.
Domingo González-LamuñoDepartment of Pediatrics, University Hospital Marqués de Valdecilla-Universidad de Cantabria, 39008 Santander, Spain.
Coral MansoDown España, 28043 Madrid, Spain.
Fernando MoldenhauerAdult Down Syndrome Outpatient Unit, Department of Internal Medicine, Hospital Universitario de La Princesa, 28006 Madrid, Spain.
María Carmona-IraguiSant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, 08025 Barcelona, Spain.
Anke HülsDepartment of Epidemiology and Gangarosa Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA.ORCID 0000-0002-6005-417X
Stephanie L ShermanDepartment of Human Genetics, School of Medicine, Emory University, Atlanta, GA 30322, USA.
Andre StrydomInstitute of Psychiatry, Psychology, and Neuroscience, Department of Forensic and Neurodevelopmental Sciences, King's College London, London SE5 8AF, UK.
Rafael de la TorreDepartment of Experimental and Health Sciences, Universitat Pompeu Fabra, 08003 Barcelona, Spain.ORCID 0000-0002-6765-1866
Mara DierssenDepartment of Experimental and Health Sciences, Universitat Pompeu Fabra, 08003 Barcelona, Spain.
Universitat Pompeu Fabra · ESEmory University · USHospital Universitario de La Princesa · ESHospital Universitario 12 De Octubre · ESInstituto Hispalense de Pediatria · ESKing's College London · GBUniversidad de Cantabria · ESUniversitat Autònoma de Barcelona · ES

Funding

Pilot Project ProgramP30ES019776 · NIEHS · EMORY UNIVERSITY · PI William Michael Caudle · 2013 to 2026
$22.6M
Medical Research Council MR/S011277/1NIEHS NIH HHS P30 ES019776
6 · The paper itself

Abstract

Whether the increased risk for coronavirus disease 2019 (COVID-19) hospitalization and death observed in Down syndrome (DS) are disease specific or also occur in individuals with DS and non-COVID-19 pneumonias is unknown. This retrospective cohort study compared COVID-19 cases in persons with DS hospitalized in Spain reported to the Trisomy 21 Research Society COVID-19 survey (

Indexed as

COVID-19Down syndromepneumoniaSARS-CoV-2

Identifiers

PMID34442043
PMCPMC8397064
OpenAlexW3193404632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.